Abstract
The objectives of a therapeutic attack on trophoblastic tumours can be defined in order of priority. The first is total and permanent elimination of the tumour with the least possible risk to the life of the patient. Subsidiary objectives are the preservation of function of the affected organs, the prevention of infection and its consequences during treatment, the avoidance of drug toxicity and a short period of hospitalisation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bagshawe, K. D., Treatment of choriocarcinoma with a combination of cytotoxic drugs. Brit. med. J., 1960 II, 426–431.
Bagshawe, K. D., The chemotherapy of chorionepithelima. In: Modern Trends in Gynecology, ed. Kellar, R. J., London: Butterworth, 1962.
Bagshawe, K. D., Trophoblastic tumours. Chemotherapy and developments. Brit. med. J. 1963 II, 1303–1307.
Bagshawe, K. D., Ultra-clean ward for cancer chemotherapy. Brit. med. J. 1964 II, 871–872.
Bagshawe, K. D., and Brooks, W. D. W., Subacute pulmonary hypertension due to chorionepithelioma. Lancet 1959 I, 653–658.
Bagshawe, K. D., and Noble, M. I.M., Cardio-respiratory aspects of trophoblastic tumors. Quart. J. Med. 35, 39–54 (1966).
Bagshawe, K. D., and Wilde, C. E., Infusion therapy for pelvic trophoblastic tumours. J. Obstet Gynec. Brit. Cwlth 71, 565–570 (1964).
Bagshawe, K. D., and Wilde, C. E., Some aspects of the excretion of gonadotrophs hormones by patients with trophoblastic tumours. J. Obstet. Gynec. Brit. Cwlth 72, 59–64 (1965).
Burchenal, J. H., and Babcock, G. M., Prevention of toxicity of massive doses of A-methopterin by citrovorum factor. Proc. Soc exp. Biol (N. Y.) 76, 382–384 (1951).
Douglas, G. W., Thomas, L., Carr, M., Cullin, N. M., and Morris, R., Trophoblast in the circulating blood during pregnancy. Amer. J. Obstet Gynec. 78, 960–973 (1959).
Dumoulin, J. G., and Bagshawe, K. D., Pregnancy following choriocarcinoma. J. Obstet. Gynec. Brit. Cwlth 70, 1068–1072 (1963).
Jacobson, W., Folic acid antagonists and cell division. Pathologie-Biologie 9, 481 (1961).
Sampey, J. R., 6-Mercaptopurine in combination chemotherapy of acute leukaemia. Int. Rec. Med. 174, 297–302 (1961).
Schmorl, G., Über das Schicksal embolisch verschleppter Plazentarzellen. Verh, dtsch. path. Ges. 8, 39–46 (1904).
Sung, H. C., Vu, P.C., and Ho, T. H., Treatment of choriocarcinoma and chorioadenoma destruens with 6-mercaptopurine and surgery. A clinical report of 93 cases. Chin. med. J. 82, 24–38 (1963).
Werkheiser, W. C., The biochemical, cellular, and pharmacological action and effects of the folic acid antagonists. Cancer Res. 23, 1277–1285 (1963).
Wilde, C. E., Orr, H., and Bagshawe, K. D., Radioimmunoassay for chorionic gonadotropin. Nature (Lond.) 205, 191–192 (1965).
Woodliff, H. J., The effect of antimetabolites on the respiration of leukaemic mouse cells. Blood 22, 199–208 (1963).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1967 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Bagshawe, K.D. (1967). The Use of 6-Mercaptopurine with Methotrexate in the Treatment of Trophoblastic Tumors. In: Holland, J.F., Hreshchyshyn, M.M. (eds) Choriocarcinoma. UICC Monograph Series, vol 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85907-6_30
Download citation
DOI: https://doi.org/10.1007/978-3-642-85907-6_30
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85909-0
Online ISBN: 978-3-642-85907-6
eBook Packages: Springer Book Archive